Abstract
Aberrant cell surface sialylation patterns have been shown to correlate with tumor progression and metastasis. However, the role of sialylation regulation of cancer multidrug resistance (MDR) remains poorly understood. This study investigated sialylation in modification on MDR in acute myeloid leukemia (AML). Using mass spectrometry (MS) analysis, the composition profiling of sialylated N-glycans differed in three pairs of AML cell lines. Real-time PCR showed the differential expressional profiles of 20 sialyltransferase (ST) genes in the both AML cell lines and bone marrow mononuclear cells (BMMCs) of AML patients. The expression levels of ST3GAL5 and ST8SIA4 were detected, which were overexpressed in HL60 and HL60/adriamycin-resistant (ADR) cells. The altered levels of ST3GAL5 and ST8SIA4 were found in close association with the MDR phenotype changing of HL60 and HL60/ADR cells both in vitro and in vivo. Further data demonstrated that manipulation of these two genes’ expression modulated the activity of phosphoinositide-3 kinase (PI3K)/Akt signaling pathway and its downstream target thus regulated the proportionally mutative expression of P-glycoprotein (P-gp) and MDR-related protein 1 (MRP1), both of which are known to be involved in MDR. Blocking the PI3K/Akt pathway by its specific inhibitor LY294002 or by Akt small interfering RNA resulted in the reduced chemosensitivity of HL60/ADR cells. Therefore, this study indicated that sialylation involved in the development of MDR of AML cells probably through ST3GAL5 or ST8SIA4 regulating the activity of PI3K/Akt signaling and the expression of P-gp and MRP1.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Deschler B, Lubbert M . Acute myeloid leukemia: epidemiology and etiology. Cancer 2006; 107: 2099–2107.
Vander Kolk DM, de Vries EG, Müller M, Vellenga E . The role of drug efflux pumps in acute myeloid leukemia. Leuk Lymphoma 2002; 43: 685–701.
Kourti M, Vavatsi N, Gombakis N, Sidi V, Tzimagiorgis G, Papageorgiou T et al. Expression of multidrug resistance 1 (mdr1), multidrug resistance-related protein 1 (mrp1), lung resistance protein (lrp), and breast cancer resistance protein (bcrp) genes and clinical outcome in childhood acute lymphoblastic leukemia. Int J Hematol 2007; 86: 166–173.
Nakano M, Saldanha R, Göbel A, Kavallaris M, Packer NH . Identification of glycan structure alterations on cell membrane proteins in desoxyepothilone B resistant leukemia cells. Mol Cell Proteomics 2011; 10: M111.009001.
Zhang Z, Zhao Y, Jiang L, Miao X, Zhou H, Jia L . Glycomic alterations are associated with multidrug resistance in human leukemia. Int J Biochem Cell Biol 2012; 44: 1244–1253.
Miyagi T, Wada T, Yamaguchi K, Hata K . Sialidase and malignancy: a minireview. Glycoconj. J 2004; 20: 189–198.
Varki N, Varki A . Diversity in cell surface sialic acid presentations: implications for biology and disease. Lab Invest 2007; 87: 851–857.
Kim YJ, Kim KS, Kim SH, Kim CH, Ko JH, Choe IS et al. Molecular cloning and expression of human Gal beta 1,3GalNAc alpha 2,3-sialytransferase (hST3Gal II). Biochem Biophys Res Commun 1996; 228: 324–327.
Pérez-Garay M, Arteta B, Pagès L, De Llorens R, De Bolòs C, Vidal-Vanaclocha F et al. Alpha2, 3-Sialyltransferase ST3Gal III modulates pancreatic cancer cell motility and adhesion in vitro and enhances its metastatic potential in vivo. PLoS One 2010; 5: e12524.
Recchi M, Hebbar M, Hornez L, Harduin-Lepers A, Peyrat JP, Delannoy P . Multiplex reverse transcription polymerase chain reaction assessment of sialyltransferase expression in human breast cancer. Cancer Res 1998; 58: 4066–4070.
Hebbar M, Krzewinski-Recchi M, Hornez L, Verdiere A, Harduin-Lepers A, Bonneterre J . Prognostic value of tumoral sialyltransferase expression and circulating E-selectin concentrations in node-negative breast cancer patients. Int J Biol Markers 2003; 18: 116–122.
Susmita M, Sarmila C, Chitra M . Elevated mRNA level of hST6Gal I and hST3Gal V positively correlates with the high risk of pediatric acute leukemia. Leukemia Res 2010; 34: 463–470.
Su H, Travis W, Mi-Ran C, Ahmad R . Human β-galactoside aipha-2, 3-sialyltransferase (ST3Gal III) attenuated Taxol-induced apoptosis in ovarian cancer cells by downregulating caspase-8 activity. Mol Cell Biochem 2009; 331: 81–88.
Sewell R, Bäckström M, Dalziel M, Gschmeissner S, Karlsson H, Noll T et al. The ST6GalNAc-I sialyltransferase localizes throughout the Golgi and is responsible for the synthesis of the tumor-associated sialyl-Tn O-glycan in human breast cancer. J Biol Chem 2006; 281: 3586–3594.
Yamada K, Mitsui Y, Kakoi N, Kinoshita M, Hayakawa T, Kakehi K . One-pot characterization of cancer cells by the analysis of mucin-type glycans and glycosaminoglycan. Anal Biochem 2012; 421: 595–606.
Martersteck C, Kedersha N, Drapp D, Tsui T, Colley K . Unique alpha 2,8-polysialylated glycoproteins in breast cancer and leukemia cells. Glycobiology 1996; 6: 289–301.
Bellacosa A, Kumar C, Di C, Testa J . Activation of AKT kinases in cancer: implications for therapeutic targeting. Adv Cancer Res 2005; 94: 29–86.
Garcia M, Alaniz L, Russo R, Alvarez E, Hajos S . PI3K/Akt inhibition modulates multidrug resistance and activates NF-kappaB in murine lymphoma cell lines. Leukemia Res 2009; 33: 288–296.
Cordo R, García M, Alaniz L, Blanco G, Alvarez E, Hajos S . Hyaluronan oligosaccharides sensitize lymphoma resistant cell lines to vincristine by modulating P-glycoprotein activity and PI3K/Akt pathway. Int J Cancer 2008; 122: 1012–1018.
Morishita N, Tsukahara H, Chayama K, Ishida T, Washio K, Miyamura T et al. Activation of Akt is associated with poor prognosis and chemotherapeutic resistance in pediatric B-pecursor acute lymphoblastic leukemia. Pediatr Blood Cancer 2012; 59: 83–89.
Parasrampuria R, Mehvar R . Divergent effects of nitric oxide donors on the biliary efflux transporters in isolated perfused rat livers: nitric oxideindependent inhibition of ABC transporters by sodium nitroprusside. Drug Metab Lett 2011; 5: 64–72.
Domon B, Aebersold R . Mass spectrometry and protein analysis. Science 2006; 312: 212–217.
Ishihara T, Fukuda I, Morita A, Takinami Y, Okamoto H, Nishimura SI et al. Development of quantitative plasma N-glycoproteomics using label-free 2-D LC-MALDI MS and its applicability for biomarker discovery in hepatocellular carcinoma. J Proteomics 2011; 74: 2159–2168.
Harvey DJ . Proteomic analysis of glycosylation: structural determination of N-and O-linked glycans by mass spectrometry. Expert Rev Proteomics 2005; 2: 87–101.
Zhu Y, Srivatana U, Ullah A, Gagneja H, Berenson CS, Lance P . Suppression of a sialyltransferase by antisense DNA reduces invasiveness of human colon cancer cells in vitro. Biochim Biophys Acta 2001; 1536: 148–160.
Schauer R . Achievements and challenges of sialic acid research. Glycoconj J 2000; 17: 485–499.
Yu S, Wang Q, Zhang J, Wu Q, Guo Z . Synthesis and evaluation of protein conjugates of GM3 derivatives carrying modified sialic acids as highly immunogenic cancer vaccine candidates. Medchemcomm 2011; 2: 524–530.
Nakayama J, Suzuki M, Suzuki M, Fukuda M . Expression profiling of glycosyltransferases and related enzymes using in situ hybridization. Methods Enzymol 2006; 416: 120–129.
Varki A . Biological roles of oligosaccharides: all of the theories are correct. Glycobiology 1993; 3: 97–130.
Dwek RA . Glycobiology: toward understanding the function of sugars. Chem Rev 1996; 96: 683–720.
Tang W, Chang SB, Hemler ME . Links between CD147 function, glycosylation, and caveolin-1. Mol Biol Cell 2004; 15: 4043–4050.
Martelli A, Nyakern M, Tabellini G, Bortul R, Tazzari PL, Evangelisti C et al. Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia. Leukemia 2006; 20: 911–928.
Billottet C, Banerjee L, Vanhaesebroeck B, Khwaja A . Inhibition of class I phosphoinositide 3-kinase activity impairs proliferation and triggers apoptosis in acute promyelocytic leukemia without affecting ATRA-induced differentiation. Cancer Res 2009; 69: 1027–1034.
Abdul-Ghani R, Serra V, Gyorffy B, Jurchott K, Solf A, Dietel M et al. The PI3K inhibitor LY294002 blocks drug export from resistant colon carcinoma cells overexpressing MRP1. Oncogene 2006; 25: 1743–1752.
Dobbin Z, Landen C . The importance of the PI3K/AKT/MTOR pathway in the progression of ovarian cancer. Int J Mol Sci 2013; 14: 8213–8227.
García MG, Alaniz LD, Cordo Russo RI, Alvarez E, Hajos SE . PI3K/Akt inhibition modulates multidrug resistance and activates NF-κB in murine lymphoma cell lines. Leukemia Res 2009; 33: 288–296.
Badura S, Tesanovic T, Pfeifer H, Wystub S, Nijmeijer BA, Liebermann M et al. Differential Effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway in acute lymphoblastic leukemia. PLoS One 2013; 8: e80070.
Wang X, Sun P, Paller A . Ganglioside GM3 blocks the activation of epidermal growth factor receptor induced by integrin at specific tyrosine sites. J Biol Chem 2003; 278: 48770–48778.
Mirkin B, Clark S, Zhang C . Inhibition of human neuroblastoma cell proliferation and EGF receptor phosphorylation by gangliosides GM1, GM3, GD1A and GT1B. Cell Prolif 2002; 35: 105–115.
Neiiendam J, Boding K, Christensen C, Li S, Volmer P, Kornerup D et al. An NCAM-derived FGF-receptor agonist, the FGL-peptide, induces neurite outgrowth and neuronal survival in primary rat neurons. J Neurochem 2004; 91: 920–935.
Tazzari P, Cappellini A, Ricci F, Evangelisti C, Papa V, Grafone T et al. Multidrug resistance-associated protein 1 expression is under the control of the phosphoinositide 3 kinase/Akt signal transduction network in human acute myelogenous leukemia blasts. Leukemia 2007; 21: 427–438.
Abdul-Ghani R, Serra V, Györffy B, Jürchott K, Solf A, Dietel M et al. The PI3K inhibitor LY294002 blocks drug export from resistant colon carcinoma cells overexpressing MRP1. Oncogene 2006; 25: 1743–1752.
Barancík M, Bohácová V, Sedlák J, Sulová Z, Breier A . LY294002, a specific inhibitor of PI3K/Akt kinase pathway, antagonizes P-glycoprotein-mediated multidrug resistance. Eur J Pharm Sci 2006; 29: 426–434.
Zhou H, Ma H, Wei W, Ji D, Song X, Jia L . B4GALT family mediates the multidrug resistance of human leukemia cells by regulating the hedgehog pathway and the expression of p-glycoprotein and multidrug resistance-associated protein 1. Cell Death and Disease 2013; 4: e654.
Acknowledgements
This work was supported by grants from National Key Basic Research and Development Program (973 program) of China (no. 2012CB822100), from National Natural Science Foundation of China (81271910), and supported by Project for Liaoning BaiQianWan Talents Program (2012921014).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on the Oncogene website
Rights and permissions
About this article
Cite this article
Ma, H., Zhou, H., Song, X. et al. Modification of sialylation is associated with multidrug resistance in human acute myeloid leukemia. Oncogene 34, 726–740 (2015). https://doi.org/10.1038/onc.2014.7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2014.7
Keywords
This article is cited by
-
Transcriptionally imprinted glycomic signatures of acute myeloid leukemia
Cell & Bioscience (2023)
-
A sialyltransferases-related gene signature serves as a potential predictor of prognosis and therapeutic response for bladder cancer
European Journal of Medical Research (2023)
-
Linking aberrant glycosylation of plasma glycoproteins with progression of myelodysplastic syndromes: a study based on plasmonic biosensor and lectin array
Scientific Reports (2023)
-
Resistance to cisplatin in human lung adenocarcinoma cells: effects on the glycophenotype and epithelial to mesenchymal transition markers
Glycoconjugate Journal (2022)
-
Role of a Disease-associated ST3Gal-4 in Non-small Cell Lung Cancer
Cell Biochemistry and Biophysics (2022)